These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32393456)

  • 21. A local criterion of fairness in sport: Comparing the property advantages of Caster Semenya and Eero Mäntyranta with implications for the construction of categories in sport.
    Camporesi S; Hämäläinen M
    Bioethics; 2021 Mar; 35(3):262-269. PubMed ID: 33184909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination and regulation of body composition in elite athletes.
    Sonksen P
    Br J Sports Med; 2018 Feb; 52(4):219-229. PubMed ID: 27879256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A question of 'fairness': Why ethics should factor in the Court of Arbitration for Sport's decision on the IAAF Hyperandrogenism Regulations.
    Camporesi S
    Br J Sports Med; 2019 Jul; 53(13):797-798. PubMed ID: 29643090
    [No Abstract]   [Full Text] [Related]  

  • 24. "Damned If You Do, Doomed If You Don't": A Socio-Medical Commentary on "Of Athletes, Bodies and Rules: Making Sense of
    Holtzman B; Ackerman KE
    J Law Med Ethics; 2021; 49(4):661-665. PubMed ID: 35006045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
    Sánchez FJ; Martínez-Patiño MJ; Vilain E
    J Sex Res; 2013; 50(2):112-5. PubMed ID: 23320653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the Caster Semenya controversy: the case of the use of genetics for gender testing in sport.
    Wonkam A; Fieggen K; Ramesar R
    J Genet Couns; 2010 Dec; 19(6):545-8. PubMed ID: 20824315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why do endocrine profiles in elite athletes differ between sports?
    Sönksen PH; Holt RIG; Böhning W; Guha N; Cowan DA; Bartlett C; Böhning D
    Clin Diabetes Endocrinol; 2018; 4():3. PubMed ID: 29445518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caster Semenya's life and achievements are cause for celebration, respect and inclusion; her exclusion is consequential.
    Carpenter M
    J Med Ethics; 2020 Sep; 46(9):593-594. PubMed ID: 32792348
    [No Abstract]   [Full Text] [Related]  

  • 29. The legacy of Caster Semenya: examining the normative basis for the construction of categories in sport.
    Camporesi S
    J Med Ethics; 2020 Sep; 46(9):597-598. PubMed ID: 32817411
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to commentaries on 'Caster Semenya, athlete classification, and fair equality of opportunity in sport'.
    Loland S
    J Med Ethics; 2020 Sep; 46(9):599-600. PubMed ID: 32826302
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a right not to know one's sex? The ethics of 'gender verification' in women's sports competition.
    Wiesemann C
    J Med Ethics; 2011 Apr; 37(4):216-20. PubMed ID: 21367768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to re-evaluate gender segregation in athletics?
    Foddy B; Savulescu J
    Br J Sports Med; 2011 Dec; 45(15):1184-8. PubMed ID: 20702382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What do we do about women athletes with testes?
    Newbould MJ
    J Med Ethics; 2016 Apr; 42(4):256-9. PubMed ID: 26545708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hurdling over sex? Sport, science, and equity.
    Ha NQ; Dworkin SL; Martínez-Patiño MJ; Rogol AD; Rosario V; Sánchez FJ; Wrynn A; Vilain E
    Arch Sex Behav; 2014 Aug; 43(6):1035-42. PubMed ID: 25085349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperandrogenism controversy in elite women's sport: an examination and critique of recent evidence.
    Sőnksen PH; Bavington LD; Boehning T; Cowan D; Guha N; Holt R; Karkazis K; Ferguson-Smith MA; Mircetic J; Bőhning D
    Br J Sports Med; 2018 Dec; 52(23):1481-1482. PubMed ID: 29351951
    [No Abstract]   [Full Text] [Related]  

  • 36. Caster semenya and a level playing field.
    Wall J
    J Med Ethics; 2020 Sep; 46(9):563-564. PubMed ID: 32855283
    [No Abstract]   [Full Text] [Related]  

  • 37. Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex-specific competition in sports, a narrative review.
    Clark RV; Wald JA; Swerdloff RS; Wang C; Wu FCW; Bowers LD; Matsumoto AM
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):15-22. PubMed ID: 30136295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fairer sex: the ethics of determining gender for athletic eligibility: commentary on "Beyond the Caster Semenya controversy: the case of the use of genetics for gender testing in sport".
    Caplan AL
    J Genet Couns; 2010 Dec; 19(6):549-50. PubMed ID: 20824314
    [No Abstract]   [Full Text] [Related]  

  • 39. Are the World Junior Championship Finalists for Middle- and Long-Distance Events Currently Competing at International Level?
    Pizzuto F; Bonato M; Vernillo G; La Torre A; Piacentini MF
    Int J Sports Physiol Perform; 2017 Mar; 12(3):316-321. PubMed ID: 27294320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of drugs and nutritional supplements in top-level track and field athletes.
    Tscholl P; Alonso JM; Dollé G; Junge A; Dvorak J
    Am J Sports Med; 2010 Jan; 38(1):133-40. PubMed ID: 19812387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.